Hong Kong Pharmaceuticals & Biotech Upcoming Dividends

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$5.5b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.

Tong Ren Tang Technologies

Market Cap: HK$4.2b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Pak Fah Yeow International

Market Cap: HK$735.5m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Sino Biopharmaceutical

Market Cap: HK$81.7b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Consun Pharmaceutical Group

Market Cap: HK$11.2b

Produces and sells pharmaceutical products in Mainland China.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.5b

Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$78.8b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$7.2b

Shanghai Haohai Biological Technology Co., Ltd.

China Resources Pharmaceutical Group

Market Cap: HK$28.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.